[DISCLOSURE] Alpha Holdings (117670) announced on Sept. 28 that its subsidiary, Alpha Biolabs, has acquired a 45 percent stake in PIPLS Pharma Korea by buying 180,000 stocks at 900 million won (US$820,868).

By Park Yuna ()